Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

Axway Software: Q3 15 sales in line with expectations, stockmarket status change confirmed

BUY, Fair Value EUR30 vs. EUR25 (+24%)

Published last October Wednesday 28, 2015

Engie: 9m-15 earnings preview

BUY, Fair Value EUR21 (+30%)

Published last October Wednesday 28, 2015

DIA: Q3 15 (first take): in line with expectations / rather positive tone from management

BUY, Fair Value EUR8,5 (+38%)

Published last October Tuesday 27, 2015

STMicroelectronics rumoured to be cutting the dividend

NEUTRAL, Fair Value EUR7.2 (+6%)

Published last October Tuesday 27, 2015

Ablynx: Pharmas lining up around the block

BUY vs. CORPORATE, Fair Value EUR17 vs. EUR16 (+42%)

Published last October Tuesday 27, 2015

Novartis: Good quarterly margins but significant miss at the top-line level

BUY, Fair Value CHF110 (+21%)

Published last October Tuesday 27, 2015

Luxottica: Q3 15 Results fairly in line despite price harmonisation in Asia-Pacific

BUY, Fair Value EUR64 (-2%)

Published last October Tuesday 27, 2015

Video Games: UBISOFT / GAMELOFT: BUY BUY before… Bye bye?

Published last October Tuesday 27, 2015
Environmental Services: Nothing to expect from Suez’ and Veolia’s Q3-15 publications

Environmental Services: Nothing to expect from Suez’ and Veolia’s Q3-15 publications

Published last October Monday 26, 2015

AstraZeneca: Despite worrying briefing documents, lesinurad gets positive recommendation from AdCom

BUY, Fair Value  5100p (+25%)

Published last October Monday 26, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities